Error processing SSI file
Error processing SSI file
Error processing SSI file
Error processing SSI file
Error processing SSI file
Error processing SSI file
  • PDF formatted for print
  • Error processing SSI file

    Weekly Report: Influenza Summary Update

    2007-2008 Influenza Season Week 50, ending December 15, 2007

    (All data are preliminary and may change as more reports are received.)


    During week 50 (December 9-15, 2007), a low level of influenza activity was reported in the United States.

    • Eighty-six (3,9 %) specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories were positive for influenza.
    • The proportion of deaths attributed to pneumonia and influenza was below the epidemic threshold.
    • The proportion of outpatient visits for influenza-like illness (ILI) and acute respiratory illness (ARI) was below national baseline levels. The Pacific region reported ILI equal to their region-specific baseline.
    • One state reported regional influenza activity; five states reported local influenza activity; 36 states, the District of Columbia, and Puerto Rico reported sporadic influenza activity; and eight states reported no influenza activity.

    National and Regional Summary of Select Surveillance Components

    Data for current week Data cumulative for the season
    Sentinel Provider ILI* DoD and VA ARI* % pos. for flu† # jurisdictions reporting regional or widespread activity‡ A (H1) A (H3) A Unsub-typed B Pediatric Deaths
    Nation Normal Normal 3,9 % 1 of 51 179 43 537 72 1
    New England Normal Normal 1,3 % 0 of 6 7 0 7 4 0
    Mid-Atlantic Normal Normal 0,6 % 0 of 3 2 0 9 5 0
    East North Central Normal Normal 3,7 % 0 of 5 4 5 5 4 0
    West North Central Normal Normal 1,4 % 0 of 7 3 2 19 5 0
    South Atlantic Normal Normal 3,8 % 0 of 9 3 8 149 22 0
    East South Central Normal Normal 0,3 % 0 of 4 2 1 0 0 0
    West South Central Normal Normal 6,2 % 0 of 4 8 23 260 8 1
    Mountain Normal Normal 9,4 % 1 of 8 95 0 41 16 0
    Pacific Elevated Normal 3,2 % 0 of 5 55 4 47 8 0

    * Elevated means the % of visits for ILI or ARI is at or above the national or region-specific baseline
    † National data is for current week; regional data is for the most recent 3 weeks.
    ‡ Includes all 50 states and the District of Columbia

    Laboratory Surveillance

    During week 50, WHO and NREVSS laboratories reported 2 207 specimens tested for influenza viruses, 86 (3,9 %) of which were positive, including 22 influenza A (H1) viruses, five influenza A (H3) viruses, 49 influenza A viruses that were not subtyped, and 10 influenza B viruses. The District of Columbia and 37 states from all nine surveillance regions have reported laboratory-confirmed influenza this season.

    Since September 30, 2007, WHO and NREVSS laboratories have tested a total of 33 163 specimens for influenza viruses and 831 (2,5 %) were positive. Among the 831 influenza viruses, 759 (91,3 %) were influenza A viruses and 72 (8,7 %) were influenza B viruses. Two hundred twenty-two (29,2 %) of the 759 influenza A viruses have been subtyped: 179 (80,6 %) were influenza A (H1) viruses and 43 (19,4 %) were influenza A (H3) viruses.

    INFLUENZA Virus Isolated
    View WHO-NREVSS Regional Bar Charts | View Chart Data | View Full Screen

    Antigenic Characterization:

    CDC has antigenically characterized 58 influenza viruses [32 influenza A (H1), 11 influenza A (H3), and 15 influenza B viruses] collected by U.S. laboratories since September 30, 2007.

    Influenza A (H1) [32]
    • All 32 viruses were characterized as A/Solomon Islands/3/2006, the influenza A (H1) component of the 2007-08 influenza vaccine for the Northern Hemisphere and the 2008 influenza A (H1) component for the Southern Hemisphere.
    Influenza A (H3) [11]
    • Four viruses were characterized as A/Wisconsin/67/2005-like, the influenza A (H3) component of the 2007-08 influenza vaccine for the Northern Hemisphere.
    • Seven viruses were characterized as A/Brisbane/10/2007-like. A/Brisbane/10/2007 is a recent antigenic variant which evolved from A/Wisconsin/67/2005-like. A/Brisbane/10/2007-like virus is the recommended influenza A (H3) component for the 2008 Southern Hemisphere vaccine.
    Influenza B (B/Victoria/02/87 and B/Yamagata/16/88 lineages) [15]
      Victoria lineage [0]
    • The recommended influenza B component for the 2007-08 influenza vaccine is a B/Malaysia/2506/2004-like virus, belonging to the B/Victoria lineage.
      Yamagata lineage [15]
    • All 15 viruses were identified as belonging to the B/Yamagata lineage.
    It is too early in the influenza season to determine which influenza viruses will predominate or how well the vaccine and circulating strains will match.

    Pneumonia and Influenza (P&I) Mortality Surveillance

    During week 50, 6,3 % of all deaths reported through the 122-Cities Mortality Reporting System were reported as due to P&I. This percentage is below the epidemic threshold of 6,6 % for week 50.

    Pneumonia And Influenza Mortality
    View Full Screen

    Influenza-Associated Pediatric Mortality

    No influenza-associated pediatric deaths were reported during week 50. One influenza-associated pediatric death has been reported during the 2007-08 season.

    Influenza-Associated Pediatric Mortality
    View Full Screen

    Influenza-Associated Pediatric Hospitalizations

    Laboratory-confirmed influenza-associated pediatric hospitalizations are monitored in two population-based surveillance networks: the New Vaccine Surveillance Network (NVSN) and the Emerging Infections Program (EIP).

    No influenza-associated pediatric hospitalizations have been reported from the NVSN.

    During September 30-December 8, 2007, the preliminary laboratory-confirmed influenza-associated hospitalization rate reported by the EIP for children 0-17 years old was 0.02 per 10,000. For children aged 0-4 years and 5-17 years, the rate was 0.03 per 10 000 and 0.01 per 10,000, respectively.

    EIP Influenza Laboratory chart
    View Full Screen

    Outpatient Illness Surveillance

    Nationwide during week 50, 1,7 % of patient visits reported through the U.S. Influenza Sentinel Provider Surveillance Network were due to influenza-like illness (ILI) and 2,5 % of patient visits to Department of Veteran's Affairs (VA) and Department of Defense (DoD) outpatient treatment facilities were for acute respiratory illness (ARI). These percentages are less than the national baselines of 2,2 % and 3,2 %, respectively. On a regional level, the percentage of visits for ILI ranged from 0,5 % to 3,4 % and the percentage of visits for ARI ranged from 1,2 % to 3 %. The Pacific region reported ILI equal to their region-specific baseline. All nine regions reported percentages of visits for ARI below their respective region-specific baselines. All five age groups reported percentages of visits for ARI below their respective age-specific baselines.

    national levels of ILI and ARI
    View Sentinel Providers Regional Charts | View Chart Data |View Full Screen
    Bar Chart for Influenza-like Illness
    View Full Screen

    Geographic Spread of Influenza as Assessed by State and Territorial Epidemiologists

    During week 50 the following influenza activity was reported:

    • Regional activity was reported by one state (Colorado).
    • Local activity was reported by five states (Arizona, Hawaii, Massachusetts, Texas, and Virginia).
    • Sporadic activity was reported by the District of Columbia, Puerto Rico, and 36 states (Alabama, Alaska, California, Connecticut, Delaware, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Michigan, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Utah, Washington, Wisconsin, and Wyoming).
    • No activity was reported by eight states (Arkansas, Idaho, Mississippi, Missouri, Ohio, South Carolina, Vermont, and West Virginia).


    A description of surveillance methods is available at:

    Error processing SSI file
    CDC logo

    Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A.   (800) 311–3435

    ; The U.S.Government 's Official Web Portal Department of Health and Human Services